Meeder Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8
| Closed | -$4K | – | 2394 |
|
|
2019
Q4 | $4K | Sell |
8
-28
| -78% | -$14K | ﹤0.01% | 1841 |
|
|
2019
Q3 | $16K | Buy |
+36
| New | +$16K | ﹤0.01% | 1383 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$1K | – | 1628 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 1568 |
|
|
2017
Q3 | $1K | Sell |
1
-3
| -75% | -$3K | ﹤0.01% | 1546 |
|
|
2017
Q2 | $5K | Sell |
4
-3
| -43% | -$3.75K | ﹤0.01% | 1191 |
|
|
2017
Q1 | $4K | Buy |
7
+5
| +250% | +$2.86K | ﹤0.01% | 1157 |
|
|
2016
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 954 |
|